U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07253272) titled 'A PET Study of ENX-104 in Healthy Volunteers' on Nov. 19.
Brief Summary: The study is designed to evaluate the D2/D3 receptor occupancy (RO), safety, tolerability, and pharmacokinetics (PK) of ENX-104 in healthy volunteers.
Study Start Date: Feb. 24
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: ENX-104
Oral solution
Recruitment Status: COMPLETED
Sponsor: Engrail Therapeutics INC
Disclaimer: Curated by HT Syndication....